A CSF-1R inhibitor both prevents and treats triple-negative breast cancer brain metastases in hematogenous preclinical models. Zhang W, Rahman S, Wu AML, Isanogle K, et al. Clin Exp Metastasis 2025;42:45.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang W, Rahman S, Wu AML, Isanogle K, et al. A CSF-1R inhibitor both prevents and treats triple-negative breast cancer brain metastases in hematogenous preclinical models. Clin Exp Metastasis 2025;42:45.
PMID: 40760255